Suscribirse

Multiple sclerosis and vascular nexus: A systematic review and meta-analysis of incidence and mortality - 03/12/24

Doi : 10.1016/j.neurol.2024.10.007 
I. Ketata a, b, , E. Ellouz a, b
a Neurology Department, University Hospital of Gabes, 6014 Gabes, Tunisia 
b Sfax Faculty of Medicine, Sfax University, Sfax, Tunisia 

Corresponding author. Neurology Department, University Hospital of Gabes, 6014 Gabes, Tunisia.Neurology Department, University Hospital of GabesGabes6014Tunisia
En prensa. Pruebas corregidas por el autor. Disponible en línea desde el Tuesday 03 December 2024

Highlights

The vascular disease incidence in MS cases was significantly higher than controls.
MS patients exhibited a significantly higher risk of heart failure, venous thromboembolism, peripheral vascular disease, and stroke.
Subgroup analysis according to follow-up period showed that the highest incidence risk of vascular disease was within the first 10years of follow-up.
MS seems to play a protective role for atrial fibrillation/flutter and high blood pressure.
Vascular disease mortality ranked third among causes of death in MS patients, following MS itself, infectious diseases, and respiratory diseases.

El texto completo de este artículo está disponible en PDF.

Abstract

Background

Vascular diseases (VDs) are increasingly studied in multiple sclerosis (MS) due to their significant impact on disability and mortality. Our aim was to evaluate VD incidence rates and determine the prevalence of VD-related mortality.

Material and methods

Our study followed the PRISMA 2020 guidelines. We searched PubMed, Google Scholar, Europe PMC, and Web of Science from the inception up to April 30th, 2024. Data analysis was performed using the R statistics package program. Sensitivity analysis, subgroup analysis, and meta-regression were conducted for significant heterogeneity.

Results

We collected 23 studies. Patients with MS exhibited significantly higher rates of VD compared with controls. Patients with MS showed a significantly higher rate of heart failure (HF), venous thromboembolism (VTE), peripheral vascular disease (PVD), and stroke, although the incidence rate of atrial fibrillation/flutter was significantly lower compared with controls. High blood pressure tended to be lower compared with controls. The highest rate of VD was within the first 10years of follow-up, significantly for myocardial infraction, VTE, and stroke, compared with controls. Regarding mortality, the prevalence of VD-related mortality among deceased individuals with MS was 16.7% [95% CI 11.8;22.0].

Conclusion

Our meta-analysis revealed a significant dynamic nexus between MS and VD. MS may act as an independent risk factor for certain VDs, yet it could also be a protective factor against others. Physicians should consider VD and mortality related to VD when managing patients with MS.

El texto completo de este artículo está disponible en PDF.

Keywords : Multiple sclerosis, Vascular disease, Mortality, Incidence, Prevalence


Esquema


© 2024  Elsevier Masson SAS. Reservados todos los derechos.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2024 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.